International Urology and Nephrology

, Volume 45, Issue 3, pp 679–686

The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis

  • Jinhong Li
  • Lu Yang
  • Chunxiao Pu
  • Yin Tang
  • Haichao Yun
  • Ping Han
Urology - Original Paper

DOI: 10.1007/s11255-013-0410-6

Cite this article as:
Li, J., Yang, L., Pu, C. et al. Int Urol Nephrol (2013) 45: 679. doi:10.1007/s11255-013-0410-6

Abstract

Objectives

This systematic review determined whether the duloxetine can get more benefits versus placebo in managing women with stress urinary incontinence (SUI) all over the world.

Methods

We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing duloxetine with placebo in these patients. The eligible RCTs were identified from the following electronic databases: Cochrane CENTRAL, Medline and EMBASE. We treated the incontinence episode frequency (IEF) as the main outcome, and the secondary outcomes were cured, average voiding interval, incontinence quality of life (I-QOL), treatment-emergent adverse events (TEAEs) and discontinuation.

Results

The review contained ten trials including 5,738 women who were randomized to take duloxetine or placebo. All arms in individual trials were comparable for various baseline characteristics. Individual studies showed a significantly greater decrease in IEF than placebo group. The total IEF responders (defined as a woman who had at least a 50 % decrease in IEF with treatment) within the duloxetine-treated women were more than the placebo-treated women (52.5 vs. 33.7 %; RR = 1.56; 95 %CI, 1.46–1.66; p < 0.00001). TEAEs were commonly experienced by both two groups (62.7 vs. 45.3 %) though they were not critical.

Authors’ conclusions

Our meta-analysis showed that significant efficacy can be found in women treated with a certain dose of duloxetine. The adverse events like nausea, constipation, dry mouth, fatigue etc. are common.

Keywords

Stress urinary incontinenceDuloxetineMedical managementSystematic reviewMeta-analysis

Abbreviations

SUI

Stress urinary incontinence

UI

Urinary incontinence

PFMT

Pelvic floor muscle training

SNRI

Serotonin and noradrenaline reuptake inhibitor

IEF

Incontinence episode frequency

I-QOL

Incontinence quality of life

TEAEs

Treatment-emergent adverse events

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Jinhong Li
    • 1
  • Lu Yang
    • 1
  • Chunxiao Pu
    • 1
  • Yin Tang
    • 1
  • Haichao Yun
    • 1
  • Ping Han
    • 1
  1. 1.Department of Urology, West China HospitalSichuan UniversityGuoxue Xiang, ChengduPeople’s Republic of China